- Obesity and Hepatocellular Carcinoma
-
Sohn W
- KMID: 2357337
- J Liver Cancer.
- 2016 Sep;16(2):86-91.
- doi: 10.17998/jlc.2016.16.2.86
Obesity is closely associated with hepatocellular carcinoma (HCC) as well as other malignancies. Obesity is an important risk factor for cancer development and overall mortality in HCC. Molecular mechanisms of... -
- CITED
-
- Close
- SHARE
-
- Close
- Sarcomatoid Intrahepatic Cholangiocarcinoma: A Rare Case of Primary Liver Cancer
-
Lee DH, Han KH, Ahn SY, Kim SS, Shin HS, Bang KB, Choi JH, Kim SB, Lee WA, Song IH
- KMID: 2357345
- J Liver Cancer.
- 2016 Sep;16(2):139-144.
- doi: 10.17998/jlc.2016.16.2.139
Sarcomatoid carcinoma arising from intrahepatic cholangiocyte, an extremely rare primary liver cancer, has highly invasive and metastatic potential. The pathogenesis of this tumor is unclear, although histogenetic mechanisms, such as... -
- CITED
-
- Close
- SHARE
-
- Close
- Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Extrahepatic Metastasis
-
Kim JS, Park SC
- KMID: 2357336
- J Liver Cancer.
- 2016 Sep;16(2):82-85.
- doi: 10.17998/jlc.2016.16.2.82
Transarterial chemoembolization (TACE) has been widely performed as a treatment for unresectable hepatocellular carcinoma (HCC). Recently extrahepatic metastasis (EHM) of HCC is increasing due to improvement of survival. Sorafenib has... -
- CITED
-
- Close
- SHARE
-
- Close
- Cause of Mortality for Hepatocellular Carcinoma Patients who were Diagnosed within the Milan Criteria
-
Lee HW, Sinn DH, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW
- KMID: 2357339
- J Liver Cancer.
- 2016 Sep;16(2):101-107.
- doi: 10.17998/jlc.2016.16.2.101
BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) is a unique condition where the cause of death might not only be due to progressive cancer, but also from liver failure. We evaluated specific causes... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Management for Hepatocellular Carcinoma with Lung Metastasis
-
Jeon HJ, Kim TH, Um SH, Seo YS, Kim HS, Lim KJ, Park SW, Lee HA, Kim DS
- KMID: 2357343
- J Liver Cancer.
- 2016 Sep;16(2):129-133.
- doi: 10.17998/jlc.2016.16.2.129
Liver cancer is the 2nd most common cause of cancer related death in Korea. Especially, patients who present extrahepatic spread of hepatocellular carcinoma (HCC) have a shorter life expectancy (50%... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Successful Hepatic Resection after Insufficient Response to Transarterial Chemoembolization and Radiation Therapy in Hepatocellular Carcinoma with Portal Vein Invasion
-
Na SK, Yim HJ, Suh SJ, Jung YK
- KMID: 2357341
- J Liver Cancer.
- 2016 Sep;16(2):118-122.
- doi: 10.17998/jlc.2016.16.2.118
Hepatocellular carcinoma (HCC) with portal vein invasion has a poor prognosis. Treatments such as transarterial chemoembolization (TACE), radiation therapy (RT), sorafenib are done as a first line treatment. But in... -
- CITED
-
- Close
- SHARE
-
- Close
- Locoregional Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
-
Hwang SY, Kim RG, Choi CW, Ahn SB
- KMID: 2357335
- J Liver Cancer.
- 2016 Sep;16(2):69-81.
- doi: 10.17998/jlc.2016.16.2.69
Hepatocellular carcinoma (HCC) patients with portal vein tumor thrombosis (PVTT) have a extremely poor prognosis. According to the Barcelona Clinic Liver Cancer guideline, sorafenib is a standard therapy in this... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatic Immunoglobulin G4-related Inflammatory Pseudotumor Mimicking Hepatocellular Carcinoma
-
Kang SH, Park SH, Park HH, Lee JR, Choe WH, Lim SD, Ko SY
- KMID: 2357347
- J Liver Cancer.
- 2016 Sep;16(2):151-154.
- doi: 10.17998/jlc.2016.16.2.151
Immunoglobulin G4-related disease is a recently recognized entity characterized by a mass-forming or regional lesion that contains an extensive infiltration of IgG4-producing plasma cells with dense fibrosis. Immunoglobulin G4-related disease... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Advanced Hepatocellular Carcinoma with Portal Vein Tumor Invasion that Showed Favorable Prognosis after Combined External Radiation Therapy and Sorafenib Therapy
-
Paik N, Sinn DH, Park HC, Jeong WK, Kim MS, Kim JH, Yang B
- KMID: 2357344
- J Liver Cancer.
- 2016 Sep;16(2):134-138.
- doi: 10.17998/jlc.2016.16.2.134
A prognosis of hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) is dismal that the median survival is 2 to 4 months without treatment. Sorafenib, the standard regimen of... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Achieving Complete Remission with Stereotactic Body Radiation Therapy in Patients with Hepatocellular Carcinoma with Macrovascular Invasion after Repeated Transarerial Chemoembolization
-
Hwang SY, Lee SM, Im JW, Jeon KJ, Ahn SB, Ji EK, Park JY, Choi CW, Yang GM
- KMID: 2357342
- J Liver Cancer.
- 2016 Sep;16(2):123-128.
- doi: 10.17998/jlc.2016.16.2.123
Transarterial chemoembolization (TACE) is the worldwide procedure performed for patients with various stage hepatoceullar carcinoma (HCC), but is not yet considered as curative treatment because of relatively high local recurrence... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnostic Performance of Diffusion-weighted Imaging for Hepatic Neuroendocrine Tumor: Comparison with Combined Diffusion-weighted Imaging and Contrast-enhanced Magnetic Resonance Imaging
-
Jang SK, Kim JH, Yu MH, Han JK
- KMID: 2357338
- J Liver Cancer.
- 2016 Sep;16(2):92-100.
- doi: 10.17998/jlc.2016.16.2.92
BACKGROUND/AIMS: To investigate the diagnostic performance of diffusion-weighted imaging (DWI) for hepatic neuroendocrine tumors (NET) compared with combined DWI and contrast-enhanced magnetic resonance imaging (MRI). METHODS: Fifteen patients with hepatic NET... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Surgical Resection in Hepatocellular Carcinoma with Pulmonary Metastasis
-
Jung WJ, Jang JY, Park JS, Lee HJ, Cho YK, Jeong SW, Lee SH, Kim SG, Cha SW, Kim YS, Cho YD, Kim HS, Kim BS
- KMID: 2357346
- J Liver Cancer.
- 2016 Sep;16(2):145-150.
- doi: 10.17998/jlc.2016.16.2.145
Hepatocellular carcinoma (HCC) is well known malignancy with poor prognosis, even after resection of the primary tumor. Sorafenib is the first-line treatment in advanced HCC, but the disease control rate... -
- CITED
-
- Close
- SHARE
-
- Close
- High-level Expression of Interleukin-17 and C-reactive Protein Predicts Tumor Progression in Unresectable Hepatocellular Carcinoma Treated by Transarterial Chemoembolization
-
Song MJ, Lee SW, Oh EJ, Jang B, Jang JW, Bae SH, Choi JY, Yoon SK
- KMID: 2357340
- J Liver Cancer.
- 2016 Sep;16(2):108-117.
- doi: 10.17998/jlc.2016.16.2.108
BACKGROUND/AIMS: Transarterial chemoembolization (TACE) is the standard locoregional treatment in patients with unresectable hepatocellular carcinoma (HCC). Angiogenesis and inflammation play important roles in tumor growth in HCC. In this study,... -
- CITED
-
- Close
- SHARE
-
- Close
